-
admin
Posts
Nota AI® Partners with Alliance Traffic Systems for Strategic Middle East Expansion
SEOUL, South Korea, Nov. 14, 2024 /PRNewswire/ — Nota AI, a leader in hardware-aware AI optimization and on-device AI solutions, has taken a significant step...
OneConnect Announces Third Quarter and Nine Months Ended September 30, 2024 Unaudited Financial Results
Revenue from third-party overseas customers increased by 23.4% YoY in first three quarters of 2024 SHENZHEN, China, Nov. 14, 2024 /PRNewswire/ — OneConnect Financial Technology...
First ASEAN Legal Business Environment Report Unveiled at the 6th China-ASEAN Legal Cooperation Forum
CHONGQING, China, Nov. 14, 2024 /PRNewswire/ — A news report from iChongqing: On November 12, the 6th China-ASEAN Legal Cooperation Forum kicked off in Southwest China’s...
L Catterton Agrees to Sell $100 Million of Shares Back to ODDITY
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) — ODDITY Tech Ltd. (NASDAQ: ODD) today announced that it has entered into a transaction with a fund managed...
NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially
Quarterly revenue growth driven by a sequential increase of 99% in branded consumer products and 103% in contract manufacturing Gross profit margin for the quarter...
Lulus Reports Third Quarter 2024 Results
Significant Sequential Quarterly Net Revenue Comp Improvement with Q3 Reaching Negative Low Single Digits Updated Outlook for Q4 and Fiscal Year 2024 CHICO, Calif., Nov....
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast
LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) — Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Third...
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2024
Haverford, PA, Nov. 13, 2024 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU), operates a diversified financial technology services company offering several different lines of business,...
VitalHub Reports Third Quarter 2024 Results
Annual Recurring Revenue (ARR) ⁽¹⁻²⁾ up 25% YoY to $53.5 million Total Revenue up 25% YoY to $16.5 million Adjusted EBITDA ⁽²⁾ up 33% YoY to $4.6...
Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology
BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living...
